Ghk-Cu Certificate Of Analysis
A verified Certificate of Analysis (COA) is the definitive benchmark for confirming the purity, identity, and structural integrity of GHK-Cu in laboratory settings. For researchers evaluating extracellular matrix remodeling and tissue repair mechanisms, lot-specific documentation ensures experimental reproducibility and eliminates baseline contamination variables.
Quick answer
A verified Certificate of Analysis (COA) is the definitive benchmark for confirming the purity, identity, and structural integrity of GHK-Cu in laboratory settings. For researchers evaluating extracellular matrix remodeling and tissue repair mechanisms, lot-specific documentation ensures experimental reproducibility and eliminates baseline contamination variables.
Key takeaways
- A [GHK-Cu](/research-peptides/ghk-cu) [Certificate of Analysis](/research-peptides/what-is-a-coa-for-peptides) (COA) is an official quality control document verifying the identity, purity, copper coordination, and safety profile of a specific lot of glycyl-L-histidyl-L-lysine copper complex.
- Reversed-Phase High-Performance Liquid Chromatography (RP-HPLC) is the gold standard method for quantifying chemical purity in synthetic peptides.
- While HPLC measures compound purity, Mass Spectrometry (MS) confirms molecular identity.
- [GHK-Cu](/research-peptides/ghk-cu) is a specialized copper peptide where the biological activity depends heavily on the precise 1:1 molar ratio between the GHK tripeptide and the $Cu^{2+}$ ion.
What is a GHK-Cu Certificate of Analysis?
A GHK-Cu Certificate of Analysis (COA) is an official quality control document verifying the identity, purity, copper coordination, and safety profile of a specific lot of glycyl-L-histidyl-L-lysine copper complex. Issued by an independent ISO 17025 accredited laboratory, it confirms structural identity via mass spectrometry and purity via reversed-phase HPLC, alongside endotoxin testing for valid in vitro research.
When purchasing research peptides, principal investigators must look beyond simple claims of purity. A complete COA provides quantitative raw data, analytical chromatograms, and mass spectra rather than arbitrary percentages. For a complex organometallic compound like GHK-Cu, the COA must confirm both the peptide backbone sequence and the stoichiometric chelation of divalent copper ions.
Without lot-traceable COA documentation, variable peptide fragments, unbound copper species, or residual synthesis solvents can severely obscure experimental outcomes in cellular culture and preclinical models. PX1 Research mandates that every batch of GHK-Cu undergoes exhaustive third-party analytical testing prior to release.
RP-HPLC Purity Quantification for GHK-Cu
Reversed-Phase High-Performance Liquid Chromatography (RP-HPLC) is the gold standard method for quantifying chemical purity in synthetic peptides. The technique separates the primary GHK-Cu complex from synthesis side products, truncated sequences, enantiomeric impurities, and unreacted precursors based on hydrophobic interactions with a stationary column phase.
A rigorous HPLC report for GHK-Cu displays a sharp, dominant absorption peak corresponding to the target molecule, measured typically at ultraviolet wavelengths of 214 nm (peptide backbone absorption) and 280 nm or specific copper-complex absorption bands. The area under the curve (AUC) for the main peak determines the percentage purity relative to total detected peak areas.
For valid preclinical research, a standard GHK-Cu COA must demonstrate a purity profile of ≥98.0% by RP-HPLC. Minor secondary peaks represent trace synthetic byproducts that must be quantified and held within strict specification limits to prevent confounding receptor binding or enzymatic assays in laboratory models.
Mass Spectrometry (MS) Identity Verification
While HPLC measures compound purity, Mass Spectrometry (MS) confirms molecular identity. Electrospray Ionization Mass Spectrometry (ESI-MS) ionizes the GHK-Cu molecules and measures their mass-to-charge ratio (m/z), producing a structural fingerprint that can be compared against the theoretical molecular weight.
The theoretical molecular weight of the free tripeptide GHK (Glycyl-L-Histidyl-L-Lysine) is 340.38 g/mol. When complexed with divalent copper ($Cu^{2+}$), the theoretical mass shifts to reflect the organometallic coordination complex ($C_{14}H_{22}CuN_6O_4$). The mass spectrum on a valid COA must display a primary m/z peak corresponding exactly to the monoisotopic mass of the GHK-Cu complex.
Absence of secondary molecular weight peaks in the mass spectrum proves that no deletion sequences (such as HK or GH fragments) or unwanted counter-ion adducts remain within the synthesized material. This level of verification is essential for studies investigating specific cell-surface receptor interactions.
Copper Content and Stoichiometric Analysis via ICP-MS
GHK-Cu is a specialized copper peptide where the biological activity depends heavily on the precise 1:1 molar ratio between the GHK tripeptide and the $Cu^{2+}$ ion. Unbound copper ions ($Cu^{2+}$) or unbound GHK peptide altered from the stoichiometric ratio can produce divergent biological responses in culture media.
Inductively Coupled Plasma Mass Spectrometry (ICP-MS) or elemental atomic absorption spectroscopy is utilized to quantify the exact weight percentage of copper within the freeze-dried peptide powder. Standard GHK-Cu contains approximately 15% to 17% elemental copper by weight, depending on the specific salt form (such as acetate or chloride).
A thorough GHK-Cu COA specifies the total elemental copper content, ensuring that the peptide is fully complexed. Free, unchelated copper can generate reactive oxygen species (ROS) via Fenton-type reactions in culture assays, making accurate elemental verification critical for cell viability studies.
Endotoxin Quantification and Bioburden Testing
Bacterial endotoxins—specifically lipopolysaccharides (LPS) derived from Gram-negative bacterial outer membranes—are common contaminants in biological manufacturing. In vitro and cell-culture research is exceptionally sensitive to endotoxin exposure, which can artificially induce inflammatory cascades, activate Toll-like receptor 4 (TLR4), and mask genuine physiological responses.
Endotoxin levels are quantified using the chromogenic Limulus Amebocyte Lysate (LAL) assay according to USP <85> guidelines. Results are reported in Endotoxin Units per milligram (EU/mg). High-grade laboratory research compounds require endotoxin levels strictly controlled below 0.1 EU/mg to 5.0 EU/mg depending on the intended assay environment.
Every batch from PX1 Research undergoes strict endotoxin validation. Confirming low bioburden on the COA guarantees that observed changes in gene expression, extracellular matrix production, or enzymatic activity are attributable solely to GHK-Cu and not lipopolysaccharide contamination.
GHK-Cu Structural Overview and Preclinical Mechanism
GHK-Cu (Glycyl-L-Histidyl-L-Lysine Copper) is a naturally occurring plasma tripeptide first isolated from human albumin. In biological systems, GHK acts as a high-affinity chelator for divalent copper ions, forming a stable complex that regulates cellular copper transport and modulates broad gene transcription networks.
Preclinical studies indicate that GHK-Cu modulates the transcription of hundreds of genes involved in tissue repair, antioxidant defense, anti-inflammatory pathways, and extracellular matrix (ECM) maintenance. The copper-tripeptide complex facilitates cellular uptake of copper, a required cofactor for key enzymes such as lysyl oxidase (LOX) and superoxide dismutase (SOD1).
Because copper ions are central to enzymatic cross-linking of structural proteins, GHK-Cu serves as a critical focus in matrix biology research. Understanding its foundational biochemistry enables researchers to design controlled experiments evaluating structural protein remodeling.
Preclinical Research: Matrix Synthesis, Remodeling, and Wound Closure
In vitro data and animal models demonstrate that GHK-Cu significantly impacts tissue repair dynamics. Grounding research shows that GHK-Cu is actively studied for collagen and elastin synthesis, playing a regulatory role in the production of collagen Type I and Type III in cultured dermal fibroblasts.
Beyond promoting structural protein synthesis, preclinical evidence reveals that GHK-Cu orchestrates skin remodeling by regulating matrix metalloproteinases (MMPs) and their tissue inhibitors (TIMPs). This dual action supports balanced ECM turnover, aiding in accelerated wound closure and reduced fibrotic scarring in rodent dermal defect models.
In vitro scratch assays and cell migration experiments further demonstrate that GHK-Cu promotes fibroblast and keratinocyte chemoattraction. Researchers utilizing high-purity GHK-Cu can study these pathway alterations without confounding factors caused by chemical degradation or residual reagent interference.
Comparative Analysis: Extracellular Remodeling Research Peptides
When evaluating wound closure, tissue repair, and extracellular matrix dynamics, researchers frequently compare GHK-Cu alongside other targeted research compounds. Understanding the mechanistic differences between these agents allows for clearer experimental design and target pathway isolation.
While GHK-Cu primarily regulates copper-dependent enzymatic cross-linking, gene expression for collagen/elastin synthesis, and fibrotic remodeling, peptides like BPC-157 operate via angiogenic upregulation, VEGFR2 activation, and focal adhesion pathways. Similarly, TB-500 functions through actin sequestration and cellular migration enhancement, while Epithalon is investigated for telomerase expression and cellular senescence pathways.
The table below outlines key preclinical characteristics across these distinct research peptides:
Laboratory Handling, Reconstitution, and Storage Specifications
To maintain the analytical specifications documented on the COA, laboratory personnel must adhere to standardized handling protocols. Lyophilized GHK-Cu powder is moisture-sensitive and should be stored at -20°C or -80°C in a dry environment prior to reconstitution.
For reconstitution, use sterile laboratory-grade solvents such as Phosphate-Buffered Saline (PBS, pH 7.4) or sterile bacteriostatic water. Avoid highly acidic or strongly basic solutions, as extreme pH shifts can disrupt copper chelation and precipitate the peptide complex out of solution.
Once reconstituted into liquid form, GHK-Cu aliquots should be stored at 4°C for short-term assays (under 7 days) or frozen at -80°C for long-term storage. Repeated freeze-thaw cycles must be avoided to prevent peptide backbone cleavage and oxidation. For detailed technical guides, consult our research peptides overview.
PX1 Research Quality Assurance and ISO 17025 Verification
At PX1 Research, quality verification is an uncompromising requirement. All research compounds are USA-manufactured in state-of-the-art, cGMP-compliant facilities and tested by independent, ISO 17025 accredited analytical laboratories.
Every batch of GHK-Cu is assigned a unique lot number linked to its corresponding COA. This ensures complete traceability from raw amino acid synthesis and copper coordination through final lyophilization and packaging. Purity is validated via RP-HPLC, molecular structure confirmed by mass spectrometry, and biological safety established via quantitative endotoxin testing.
Research institutions and commercial laboratories requiring bulk quantities or dedicated lot reservations can coordinate directly through our wholesale portal. PX1 Research guarantees that the material received matches the exact analytical data published on its Certificate of Analysis.
Frequently Asked Questions
What key metrics should be verified on a GHK-Cu COA?
A valid GHK-Cu COA must state RP-HPLC purity (≥98.0%), Mass Spectrometry confirmation of molecular weight, total elemental copper content via ICP-MS, endotoxin limits (LAL assay), net peptide content, and lot-specific batch numbers.
Why is mass spectrometry essential for GHK-Cu analysis?
Mass spectrometry confirms the exact molecular mass of the GHK-Cu complex. It proves structural identity and verifies the absence of truncated peptide sequences, deletion fragments, or unchelated species.
How does copper stoichiometry impact GHK-Cu research quality?
GHK-Cu requires a precise 1:1 ratio of GHK tripeptide to divalent copper. Excess free copper can induce oxidative stress via Fenton reactions, while uncomplexed GHK lacks proper organometallic transport dynamics.
What are acceptable endotoxin limits for GHK-Cu in laboratory experiments?
For sensitive cell culture and in vitro assays, endotoxin levels should ideally remain under 1.0 EU/mg (and strictly below 5.0 EU/mg) to prevent non-specific inflammatory activation via TLR4 pathways.
How should lyophilized GHK-Cu be stored upon receipt in the laboratory?
Lyophilized GHK-Cu powder should be stored at -20°C or -80°C in a desiccated environment. Desiccated storage protects the lyophilized cake from ambient humidity and hydrolysis.
What solvent is recommended for reconstituting GHK-Cu for in vitro assays?
Sterile Phosphate-Buffered Saline (PBS, pH 7.4) or sterile bacteriostatic water is recommended. Neutral pH buffers preserve the copper-tripeptide coordination complex.
What is the physical appearance of high-purity GHK-Cu powder?
High-purity GHK-Cu lyophilized powder exhibits a distinct blue color due to the coordination complex of $Cu^{2+}$ ions within the tripeptide matrix. White or off-white powder indicates lack of copper chelation.
How does PX1 Research ensure lot-to-lot batch consistency?
PX1 Research subjects every individual production lot to independent third-party testing at ISO 17025 accredited laboratories, releasing compounds only when HPLC, MS, and endotoxin metrics meet strict specifications.
Related pages
All products are sold strictly for laboratory and research use only. Not for human or veterinary use, diagnosis, treatment or consumption. Statements have not been evaluated by the FDA.